Rejoin your ADC combination speakers and attendees after lunch for a closing panel discussion to discuss, debate and evaluate the opportunities and challenges in combination clinical performance, optimizing partner selection, the power of ADC sequencing and dual payload conjugates, and more. Make sure to come with your thoughts and questions prepared!

Discussion Highlights Include:

• Contextualizing the growing importance of ADC combination therapies as more ADCs advance to earlier-line patient therapies
• Understanding the best rationale to smartly select appropriate ADC combination partners
• Undergoing preclinical investigation to support and justify clinical ADC
• combination trials
• Evaluating the ability of ADC sequencing and dual payload combinations to combat resistance to payloads